Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERVIN R RIANO-MARIN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1265863898
CMS profile
1320464
Location
FLUSHING, NY

General Payments · PY2018–2024

$5,421.72

  • Reported across 58 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$421.57

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $315.03 13
Education $106.54 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $238.60 8
PFIZER INC. $55.39 2
Organon LLC $51.94 2
Sumitomo Pharma America, Inc. $47.10 2
SHIELD THERAPEUTICS INC $28.54 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24.87 1
PY2019 $368.20 10
PY2020 $3,000.00 1
PY2021 $200.19 10
PY2022 $883.58 4
PY2023 $523.31 17
PY2024 $421.57 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $16.48 03/01/2024 Food and Beverage Undisputed 01/23/2026 1139297514 CMS
Astellas Pharma US Inc $6.55 04/18/2024 Education Undisputed 01/23/2026 1139321008 CMS
Astellas Pharma US Inc $15.68 04/19/2024 Food and Beverage Undisputed 01/23/2026 1139326576 CMS
Astellas Pharma US Inc $28.57 07/18/2024 Food and Beverage Undisputed 01/23/2026 1139270598 CMS
Astellas Pharma US Inc $13.78 09/10/2024 Food and Beverage Undisputed 01/23/2026 1139399889 CMS
Astellas Pharma US Inc $99.99 10/31/2024 Education Undisputed 01/23/2026 1139426750 CMS
Astellas Pharma US Inc $28.53 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139437142 CMS
Astellas Pharma US Inc $29.02 12/18/2024 Food and Beverage Undisputed 01/23/2026 1139445326 CMS
Organon Llc $30.36 03/22/2024 Food and Beverage Undisputed 01/23/2026 1136299164 CMS
Organon Llc $21.58 04/02/2024 Food and Beverage Undisputed 01/23/2026 1136299166 CMS
PFIZER INC. $26.95 01/24/2024 Food and Beverage Undisputed 01/23/2026 1131059823 CMS
PFIZER INC. $28.44 02/27/2024 Food and Beverage Undisputed 01/23/2026 1131307254 CMS
SHIELD THERAPEUTICS INC $28.54 11/21/2024 Food and Beverage Undisputed 01/23/2026 1150155294 CMS
Sumitomo Pharma America, Inc. $21.90 01/04/2024 Food and Beverage Undisputed 01/23/2026 1148909454 CMS
Sumitomo Pharma America, Inc. $25.20 06/06/2024 Food and Beverage Undisputed 01/23/2026 1148909456 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.